Will LMND going to beat the earnings significantly today?

Lemonade's earnings are not expected to beat expectations significantly today. Here's an analysis based on the available data:

1. Analyst Expectations: The consensus EPS Estimate for Q3 2024 is -$1.02, representing a year-over-year change of -15.9%. The consensus Revenue Estimate is $126.48 million, which is a 10.5% increase year-over-year.

2. Historical Revisions: Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 6 downward. This indicates a general trend of decreasing expectations for the company's performance.
3. Recent Performance: Lemonade reported earnings per share (EPS) of ($0.81) for the quarter, which was higher than analysts' consensus estimates of ($0.88) by $0.07. However, this was a one-quarter positive variance and does not suggest a consistent trend of outperformance.
4. Market Sentiment: The stock has been disappointing investors over its four years of being a public company, with a 73% decline since its first-day closing price. The market appears to be cautious, with recent estimate revisions pointing to a decline in earnings on higher revenues.
5. Earnings Release Timing: The earnings report for Q3 2024 is scheduled to be released on October 30, 2024, after market close. This timing allows for some market reaction but does not provide a full day of trading to gauge the impact of the earnings report.

LMND

Date	Earnings Release Date	Earnings Release Time	Financial Report Period
20231001-20241001	20240227	After Market Close	2023 Q4
20231001-20241001	20240430	--	2024 Q1
20231001-20241001	20240730	--	2024 Q2
20231001-20241001	20241030	After Market Close	2024 Q3

Name
LemonadeLMND
LemonadeLMND
LemonadeLMND
LemonadeLMND

View 1 result

In conclusion, while there is some positive variance in the latest earnings report, the overall trend of estimate revisions and market sentiment suggests that LMND is not expected to beat earnings significantly today. The company is anticipated to deliver a year-over-year decline in earnings on higher revenues, which is a widely known consensus outlook.